美国医药公司诺瓦瓦克斯(Novavax Inc.)在周二盘后大幅下挫7.42%,引发市场关注。这一急跌与诺华宣布终止与英国卫生安全局就COVID-19疫苗供应协议的消息有关。
根据诺华的公告,双方已就终止该项COVID-19疫苗供应协议达成和解。尽管公司并未透露具体细节,但分析人士普遍认为,这将对诺华的收入和利润预期产生负面影响。
作为新冠疫苗的主要供应商之一,诺华此前曾与英国政府签订一份价值8.85亿英镑(约合10.7亿美元)的合同。该协议的终止无疑将给诺华的疫苗业务带来重大冲击,投资者对公司前景的担忧也因此上升,从而推动诺华股价下跌。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.